And it depends on you how soon it will be developed
A relatively low-tech stock trade is making Tesla Inc.’s dizzying rally look like an under-performance.
Agreement provides option for European Union Member States to secure up to 200 million additional doses for a total of up to 400 million doses
ECE professor's method measures naturally occurring electron transfers
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, today announced a partnership with the United Kingdom’s (UK) National Health Service (NHS) to help transform cancer outcomes by making GRAIL’s multi-cancer early detection blood test, Galleri™, available to UK patients starting in 2021.